{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:55:00Z","timestamp":1791006900125,"version":"4.1.0"},"reference-count":14,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.26028","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:11:03Z","timestamp":1785363063000},"page":"244-247","source":"Crossref","is-referenced-by-count":0,"title":["Long-term remission of chronic-type adult T-cell leukemia\/lymphoma associated with Graves\u2019 disease treated with methimazole"],"prefix":"10.3960","volume":"66","author":[{"given":"Shigeo","family":"Fuji","sequence":"first","affiliation":[{"name":"Department of Hematology, Osaka International Cancer Institute, Osaka, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Laboratory of Viral Oncology and Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Watanabe","sequence":"additional","affiliation":[{"name":"IMSUT Clinical Flow Cytometry Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"IMSUT Clinical Flow Cytometry Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Laboratory of Viral Oncology and Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79: 428-437.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Cook LB, Fuji S, Hermine O <i>et al.<\/i> Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report. J Clin Oncol. 2019; 37: 677-687.","DOI":"10.1200\/JCO.18.00501"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Fuji S, Tokunaga M, Utsunomiya A <i>et al.<\/i> Improving outcome prediction in indolent ATL by subdividing intermediate risk into low- and high-intermediate groups. Ann Hematol. 2025; 104: 2429-2436.","DOI":"10.1007\/s00277-025-06319-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kobayashi S, Nakano K, Watanabe E <i>et al.<\/i> CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia\/lymphoma. Clin Cancer Res. 2014; 20: 2851-2861.","DOI":"10.1158\/1078-0432.CCR-13-3169"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Yamagishi M, Kubokawa M, Kuze Y <i>et al.<\/i> Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun. 2021; 12: 4821.","DOI":"10.1038\/s41467-021-25101-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Debernardi M, Correa A, Alvarado L <i>et al.<\/i> Thyroid hormones contribute to JAK\/STAT pathway abnormal activation, promoting T-cell lymphoma dissemination. Blood Adv. 2025; 9: 4067-4080.","DOI":"10.1182\/bloodadvances.2024015332"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Cayrol F, D\u00edaz Flaqu\u00e9 MC, Fernando T <i>et al.<\/i> Integrin \u03b1v\u03b23 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells. Blood. 2015; 125: 841-851.","DOI":"10.1182\/blood-2014-07-587337"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Cayrol F, Sterle HA, D\u00edaz Flaqu\u00e9 MC, Barreiro Arcos ML, Cremaschi GA. Non-genomic Actions of Thyroid Hormones Regulate the Growth and Angiogenesis of T Cell Lymphomas. Front Endocrinol (Lausanne). 2019; 10: 63.","DOI":"10.3389\/fendo.2019.00063"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Cayrol F, Revuelta MV, Debernardi M <i>et al.<\/i> Inhibition of Integrin \u03b1V\u03b23 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma. Mol Cancer Ther. 2022; 21: 1485-1496.","DOI":"10.1158\/1535-7163.MCT-22-0093"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hirao N, Iijima T, Tanuma D <i>et al.<\/i> Effects of treatment with methimazole on circulating CD4(+) and CD8(+) T cells positive for programed cell death protein-1 and on subsets of CD4(+) T cells in untreated hyperthyroid patients with Graves\u2019 disease. Clin Endocrinol (Oxf). 2022; 97: 841-848.","DOI":"10.1111\/cen.14788"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Iijima T, Jojima T, Hosonuma S <i>et al.<\/i> Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves\u2019 disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy. Endocr J. 2021; 68: 1187-1195.","DOI":"10.1507\/endocrj.EJ20-0717"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ohmoto A, Fuji S. Non-cancerous complications in HTLV-1 carriers. Expert Rev Anti Infect Ther. 2024; 22: 307-316.","DOI":"10.1080\/14787210.2024.2336547"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Fuji S, Assone T, Casseb J. Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority. Expert Rev Anti Infect Ther. 2026; 24: 203-212.","DOI":"10.1080\/14787210.2026.2635426"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ohmoto A, Fuji S. Spontaneous regression in mature T-cell non-Hodgkin lymphoma. Expert Rev Hematol. 2025; 18: 47-55.","DOI":"10.1080\/17474086.2024.2439469"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/3\/66_26028\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:34:55Z","timestamp":1791005695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/3\/66_26028\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.26028","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26028"}}